Company: LICN
Filing Date: 2025-01-29
Form Type: 424B5
Source: 0001213900-25-007741
Chunk: 113

Company: Lichen International Ltd
Filing Date: 2025-01-29
Form: 424B5
Chunk 113
---
 or conducting any offering, and these risks could result in a material adverse change in our operations,
limit our ability to offer or continue to offer securities to investors, or cause such securities to significantly decline in value or
become worthless. As the Circular and Trial Measures were newly published, there exists uncertainty with respect to the filing requirements
and their implementation. Any failure or perceived failure of us to fully comply with such new regulatory requirements could significantly
limit or completely hinder our ability to offer or continue to offer securities to investors, cause significant disruption to our business
operations, and severely damage our reputation, which could materially and adversely affect our financial condition and results of operations
and could cause the value of our securities to significantly decline or be worthless.

<div align='center'>15</div>

As of the date of this prospectus, according to
our PRC counsel, Tianyuan Law Firm, although we are required to complete the filing procedure in connection with our offering under the
Trial Measures, no relevant PRC laws or regulations in effect require that we obtain permission from any PRC authorities to issue securities
to foreign investors, and we have not received any inquiry, notice, warning, sanction, or any regulatory objection to this offering from
the CSRC, the CAC, or any other PRC authorities that have jurisdiction over our operations. If it is determined that we are subject to
filing requirements imposed by the CSRC under the Overseas Listing Regulations or approvals from other PRC regulatory authorities or other
procedures, including the cybersecurity review under the revised Cybersecurity Review Measures, for our future offshore offerings, it
would be uncertain whether we can or how long it will take us to complete such procedures or obtain such approval and any such approval
could be rescinded. Any failure to obtain or delay in completing such procedures or obtaining such approval for our offshore offerings,
or a rescission of any such approval if obtained by us, would subject us to sanctions by the CSRC or other PRC regulatory authorities
for failure to file with the CSRC or failure to seek approval from other government authorization for our offshore offerings. These regulatory
authorities may impose fines and penalties on our operations in China, limit our ability to pay dividends outside of China, limit our
operating privileges in China, delay or restrict the repatriation of the proceeds from our offshore offerings into China or take other
actions that could materially and adversely affect our business, financial condition, results of operations, and prospects, as well as
the trading